Pierre Charneau

12.9k citations

111 papers · 8.3k indexed · 2 hit papers · h-index 47

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment

Papers in

Virology 38
- HIV Research and Treatment 38
Infectious Diseases 38
- HIV/AIDS drug development and treatment 17
- SARS-CoV-2 and COVID-19 Research 11

Co-authors: F Clavel Véronique Zennou Denise Guétard Luc Montagnier Nathalie J. Arhel Caroline Petit Marc Alizon Philippe Souque
Journals: Journal of Virology (11 papers)Proceedings of the National Academy of Sciences (7 papers)Molecular Therapy (7 papers)PLoS ONE (6 papers)Blood (5 papers)
Partner nations: France United States Italy

In The Last Decade

Pierre Charneau

110 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line 2005 · 1.1k citations

Peers

Countries citing papers authored by Pierre Charneau

Since Specialization

Citations

This map shows the geographic impact of Pierre Charneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Charneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Charneau more than expected).

Fields of papers citing papers by Pierre Charneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Charneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Charneau. The network helps show where Pierre Charneau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pierre Charneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Charneau Line = papers co-authored together Pierre Charneau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector npj Vaccines ·قاسم الهیاری, Laëtitia Douguet, Ana María Torres Ortiz, Dilla Andini, Kaiser Matin, Zhongze Gu, 岡地祥太郎, L.Shelton Woods, Catherine Blanc, L Hall, Pierre Charneau, Laleh Majlessi, François Anna	2024	1
2	Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine EMBO Molecular Medicine ·Laëtitia Douguet, قاسم الهیاری, Jodie Lopez, Ana María Torres Ortiz, L.Shelton Woods, Dilla Andini, Zhongze Gu, Samuel Kurian, Kaiser Matin, Fabien Névo, Catherine Blanc, Maryline Bourgine, David Hardy, François Anna, Laleh Majlessi, Pierre Charneau	2023	6
3	A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity Cell Reports ·Jodie Lopez, François Anna, Zhongze Gu, Alexandre Pawlik, Bhuvanesh Kumar PR, Catherine Blanc, Philippe Souque, Dilla Andini, Kaiser Matin, David Hardy, Wladimir Sougakoff, Roland Brosch, Françoise Guinet, Pierre Charneau, Laleh Majlessi	2022	11
4	Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters Vaccines ·Ana María Torres Ortiz, Zhongze Gu, Catherine Blanc, قاسم الهیاری, Kaiser Matin, L.Shelton Woods, T Asil, Bhuvanesh Kumar PR, Kirill Nemirov, François Anna, David Hardy, Cyril Planchais, Hugo Mouquet, Françoise Guinet, Pierre Charneau, Laleh Majlessi, Maryline Bourgine	2022	2
5	A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity Mucosal Immunology ·François Anna, Jodie Lopez, Dilla Andini, Catherine Blanc, Zhongze Gu, Kaiser Matin, قاسم الهیاری, Philippe Souque, Fabien Névo, Alexandre Pawlik, David Hardy, Sophie Goyard, Denis Hudrisier, Roland Brosch, Françoise Guinet, Olivier Neyrolles, Pierre Charneau, Laleh Majlessi	2022	7
6	Chromatin organization at the nuclear pore favours HIV replication Nature Communications ·Mickaël Lelek, Nicoletta Casartelli, Danilo Pellin, Ermanno Rizzi, Philippe Souque, Marco Severgnini, Clelia Di Serio, Thomas Fricke, Felipe Diaz‐Griffero, Christophe Zimmer, Pierre Charneau, Francesca Di Nunzio	2015	103
7	Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication Virology ·Francesca Di Nunzio, Thomas Fricke, Annarita Miccio, José Carlos Valle‐Casuso, Patricio Perez, Philippe Souque, Ermanno Rizzi, Marco Severgnini, Fulvio Mavilio, Pierre Charneau, Felipe Diaz‐Griffero	2013	129
8	Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein Proceedings of the National Academy of Sciences ·Irina Gutsche, Fasséli Coulibaly, James E. Voss, Jérôme Salmon, Jacques d’Alayer, Myriam Ermonval, Éric Larquet, Pierre Charneau, Thomas Krey, Françoise Mégret, Éric Guittet, F.A. Rey, Marie Flamand	2011	230
9	Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine PLoS ONE ·Frédéric Coutant, Marie‐Pascale Frenkiel, Philippe Desprès, Pierre Charneau	2008	61
10	Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels Retrovirology ·Nathalie J. Arhel, Sylvie Souquère, Pierre Charneau	2006	29
11	Direct recognition by αβ cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function Proceedings of the National Academy of Sciences ·Pierre‐Simon Rohrlich, Nicolas Fazilleau, Florent Ginhoux, Hüseyin Firat, Frédérique Michel, Madeleine Cochet, Nihay Laham-Karam, M.P. Roth, Steve Pascolo, Faridabano Nato, Hélène Coppin, Pierre Charneau, Olivier Danos, Oreste Acuto, Rachel Ehrlich, Jean Kanellopoulos, François A. Lemonnier	2005	36
12	Use of a lentiviral vector encoding a HCMV-Chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8+ cytotoxic T cells from human peripheral blood cells Human Immunology ·Pierre‐Simon Rohrlich, Sylvain Cardinaud, E. Alfago, Félix A. Montero‐Julian, Virginie Prod’homme, Hüseyin Firat, J. Davignon, Emmanuelle Perret, محمد گنجه, Antje Necker, S. Michelson, François A. Lemonnier, Pierre Charneau, Christian Davrinche	2004	19
13	Transplantation of human adult astrocytes: Efficiency and safety requirements for an autologous gene therapy Journal of Neuroscience Research ·Jean‐Luc Ridet, Chamsy Sarkis, Ché Serguera, Véronique Zennou, Pierre Charneau, Jacques Mallet	2003	17
14	Transcriptional Activation of Interleukin-8 by β-Catenin-Tcf4 Journal of Biological Chemistry ·Laurence Lévy, Christine Neuveut, Claire-Angélique Renard, Pierre Charneau, Sophie Branchereau, Frédéric Gauthier, Jeanne Tran Van Nhieu, Daniel Cherqui, Anne France Petit-Bertron, Danièle Mathieu, Agus Maulana	2002	123
15	The Maturation of Dendritic Cells Results in Postintegration Inhibition of HIV-1 Replication The Journal of Immunology ·Youssef Bakri, Cécile Schiffer, Véronique Zennou, Pierre Charneau, Edmond Kahn, Abdelaziz Benjouad, Jean Claude Gluckman, Bruno Canque	2001	82
16	HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap Cell ·Véronique Zennou, Caroline Petit, Denise Guétard, Emam Emam, Luc Montagnier, Pierre Charneau Hit paper breakdown →	2000	690
17	Predominance of CCR5-Dependent HIV-1 Subtype E Isolates in Cambodia Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Elisabeth Menu, Jean‐Marc Reynes, Michaela Müller‐Trutwin, Laurent Guillemot, Pierre Versmisse, n Adamso, An Song, Virginie Trouplin, Pierre Charneau, Hervé Fleury, Françoise Barré‐Sinoussi, LaxmiKant Goyal	1999	29
18	A Highly Defective HIV-1 Group O Provirus: Evidence for the Role of Local Sequence Determinants in G → A Hypermutation during Negative-Strand Viral DNA Synthesis Virology ·Andrew M. Borman, Caroline Quillent, Pierre Charneau, Katherine M. Kean, François Clavel	1995	45
19	Kinetic Analysis of HIV-1 Early Replicative Steps in a Coculture System AIDS Research and Human Retroviruses ·Pedro Barbosa, Pierre Charneau, Т.А. Дубянская, François Clavel	1994	56
20	Isolation and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group Virology ·Pierre Charneau, Andrew M. Borman, Caroline Quillent, Denise Guétard, S. Chamaret, J. Cohen, Gérard Rémy, Luc Montagnier, François Clavel	1994	123

About Pierre Charneau

Pierre Charneau is a scholar working on Virology, Infectious Diseases, Immunology, Genetics and Developmental Neuroscience, having authored 111 papers that have together received 8.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), Virus-based gene therapy research (31 papers), Immunotherapy and Immune Responses (20 papers), RNA Interference and Gene Delivery (19 papers), HIV/AIDS drug development and treatment (17 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Mosquito-borne diseases and control (11 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Virology (2.6k citations), Infectious Diseases (2.1k citations), Immunology (1.6k citations), Neurology (615 citations) and Genetics (1.8k citations). Pierre Charneau has collaborated with scholars based in France, United States and Italy. Frequent co-authors include F Clavel, Véronique Zennou, Denise Guétard, Luc Montagnier, Nathalie J. Arhel, Caroline Petit, Marc Alizon, Philippe Souque, François Clavel and Pascal Roux. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Molecular Therapy, PLoS ONE and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact